Advertisement

Endemic mycosis

  • Chadi A. Hage
  • Kenneth S. Knox
  • George A. Sarosi
Part of the Perspective on Critical Care Infectious Diseases book series (CCID, volume 9)

Keywords

Parasitic Infection Acquire Immunodeficiency Syndrome Histoplasma Capsulatum Chronic Meningitis Bronchial Washing 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Goodwin, R.A., Jr. and R.M. Des Prez, State of the art: histoplasmosis. Am Rev Respir Dis, 1978. 117(5): p. 929–56.PubMedGoogle Scholar
  2. 2.
    Sarosi, G.A. and S.F. Davies, Blastomycosis. Am Rev Respir Dis, 1979. 120(4): p. 911–38.PubMedGoogle Scholar
  3. 3.
    Drutz, D.J. and A. Catanzaro, Coccidioidomycosis. Part I. Am Rev Respir Dis, 1978. 117(3): p. 559–85.PubMedGoogle Scholar
  4. 4.
    Davies, S.F., M. Khan, and G.A. Sarosi, Disseminated histoplasmosis in immunologically suppressed patients. Occurrence in a nonendemic area. Am J Med, 1978. 64(1): p. 94–100.PubMedCrossRefGoogle Scholar
  5. 5.
    Goodwin, R.A., Jr., et al., Disseminated histoplasmosis: clinical and pathologic correlations. Medicine (Baltimore), 1980. 59(1): p. 1–33.Google Scholar
  6. 6.
    Manfredi, R., et al., Histoplasmosis capsulati and duboisii in Europe: the impact of the HIV pandemic, travel and immigration. Eur J Epidemiol, 1994. 10(6): p. 675–81.PubMedCrossRefGoogle Scholar
  7. 7.
    Edwards, L.B., et al., An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States. Am Rev Respir Dis. Vol. 99. 1969. Suppl:1–132.PubMedGoogle Scholar
  8. 8.
    Hammerman, K.J., K.E. Powell, and F.E. Tosh, The incidence of hospitalized cases of systemic mycotic infections. Sabouraudia, 1974. 12(1): p. 33–45.PubMedGoogle Scholar
  9. 9.
    Wheat, L.J., et al., A large urban outbreak of histoplasmosis: clinical features. Ann Intern Med, 1981. 94(3): p. 331–7.PubMedGoogle Scholar
  10. 10.
    Wheat, L.J., et al., Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine (Baltimore), 1990. 69(6): p. 361–74.Google Scholar
  11. 11.
    Procknow, J.J., M.I. Page, and C.G. Loosli, Early pathogenesis of experimental histoplasmosis. Arch Pathol, 1960. 69: p: 413–26.PubMedGoogle Scholar
  12. 12.
    Zhou, P., G. Miller, and R.A. Seder, Factors involved in regulating primary and secondary immunity to infection with Histoplasma capsulatum: TNF-alpha plays a critical role in maintaining secondary immunity in the absence of IFN-gamma. J Immunol, 1998. 160(3): p. 1359–68.PubMedGoogle Scholar
  13. 13.
    Allendoerfer, R., G.P. Biovin, and G.S. Deepe, Jr., Modulation of immune responses in murine pulmonary histoplasmosis. J Infect Dis, 1997. 175(4): p. 905–14.PubMedCrossRefGoogle Scholar
  14. 14.
    Allendorfer, R., G.D. Brunner, and G.S. Deepe, Jr., Complex requirements for nascent and memory immunity in pulmonary histoplasmosis. J Immunol, 1999. 162(12): p. 7389–96.PubMedGoogle Scholar
  15. 15.
    Allendoerfer, R. and G.S. Deepe, Jr., Intrapulmonary response to Histoplasma capsulatum in gamma interferon knockout mice. Infect Immun, 1997. 65(7): p. 2564–9.PubMedGoogle Scholar
  16. 16.
    Wood, K.L., et al., Histoplasmosis after treatment with anti-tumor necrosis factor-alpha therapy. Am J Respir Crit Care Med, 2003. 167(9): p. 1279–82.PubMedCrossRefGoogle Scholar
  17. 17.
    Straub, M. and J. Schwarz, The healed primary complex in histoplasmosis. Am J Clin Pathol, 1955. 25(7): p. 727–41.PubMedGoogle Scholar
  18. 18.
    Wheat, J., Histoplasmosis. Experience during outbreaks in Indianapolis and review of the literature. Medicine (Baltimore), 1997. 76(5): p. 339–54.CrossRefGoogle Scholar
  19. 19.
    Conces, D.J., Jr., et al., Disseminated histoplasmosis in AIDS: findings on chest radiographs. AJR Am J Roentgenol, 1993. 160(1): p. 15–9.PubMedGoogle Scholar
  20. 20.
    Davies, S.F., R.W. McKenna, and G.A. Sarosi, Trephine biopsy of the bone marrow in disseminated histoplasmosis. Am J Med, 1979. 67(4): p. 617–22.PubMedCrossRefGoogle Scholar
  21. 21.
    Wheat, L.J., T.G. Slama, and M.L. Zeckel, Histoplasmosis in the acquired immune deficiency syndrome. Am J Med, 1985. 78(2): p. 203–10.PubMedCrossRefGoogle Scholar
  22. 22.
    Johnson, P.C., R.J. Hamill, and G.A. Sarosi, Clinical review: progressive disseminated histoplasmosis in the AIDS patient. Semin Respir Infect, 1989. 4(2): p. 139–46.PubMedGoogle Scholar
  23. 23.
    Wheat, L.J., et al., Risk factors for disseminated or fatal histoplasmosis. Analysis of a large urban outbreak. Ann Intern Med, 1982. 96(2): p. 159–63.PubMedGoogle Scholar
  24. 24.
    Sarosi, G.A., et al., Disseminated histoplasmosis: results of long-term follow-up. A center for disease control cooperative mycoses study. Ann Intern Med, 1971. 75(4): p. 511–6.PubMedGoogle Scholar
  25. 25.
    Wheat, L.J., B.E. Batteiger, and B. Sathapatayavongs, Histoplasma capsulatum infections of the central nervous system. A clinical review. Medicine (Baltimore), 1990. 69(4): p. 244–60.Google Scholar
  26. 26.
    Hawkins, S.S., D.W. Gregory, and R.H. Alford, Progressive disseminated histoplasmosis; favorable response to ketoconazole. Ann Intern Med, 1981. 95(4): p. 446–9.PubMedGoogle Scholar
  27. 27.
    Vail, G.M., et al., Incidence of histoplasmosis following allogeneic bone marrow transplant or solid organ transplant in a hyperendemic area. Transpl Infect Dis, 2002. 4(3): p. 148–51.PubMedCrossRefGoogle Scholar
  28. 28.
    Davies, S.F., Serodiagnosis of histoplasmosis. Semin Respir Infect, 1986. 1(1): p. 9–15.PubMedGoogle Scholar
  29. 29.
    Prechter, G.C. and U.B. Prakash, Bronchoscopy in the diagnosis of pulmonary histoplasmosis. Chest, 1989. 95(5): p. 1033–6.PubMedGoogle Scholar
  30. 30.
    Wheat, L.J., et al., Diagnosis of histoplasmosis in patients with the acquired immunodeficiency syndrome by detection of Histoplasma capsulatum polysaccharide antigen in bronchoalveolar lavage fluid. Am Rev Respir Dis, 1992. 145(6): p. 1421–4.PubMedGoogle Scholar
  31. 31.
    Salzman, S.H., R.L. Smith, and C.P. Aranda, Histoplasmosis in patients at risk for the acquired immunodeficiency syndrome in a nonendemic setting. Chest, 1988. 93(5): p. 916–21.PubMedGoogle Scholar
  32. 32.
    Wheat, J., et al., Cross-reactivity in Histoplasma capsulatum variety capsulatum antigen assays of urine samples from patients with endemic mycoses. Clin Infect Dis, 1997. 24(6): p. 1169–71.PubMedGoogle Scholar
  33. 33.
    Wheat, L.J., et al., Histoplasmosis relapse in patients with AIDS: detection using Histoplasma capsulatum variety capsulatum antigen levels. Ann Intern Med, 1991. 115(12): p. 936–41.PubMedGoogle Scholar
  34. 34.
    Wheat, L.J., et al., Effect of successful treatment with amphotericin B on Histoplasma capsulatum variety capsulatum polysaccharide antigen levels in patients with AIDS and histoplasmosis. Am J Med, 1992. 92(2): p. 153–60.PubMedCrossRefGoogle Scholar
  35. 35.
    Dismukes, W.E., et al., Itraconazole therapy for blastomycosis and histoplasmosis. NIAID Mycoses Study Group. Am J Med, 1992. 93(5): p. 489–97.PubMedCrossRefGoogle Scholar
  36. 36.
    Wheat, J., et al., Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome. The National Institute of Allergy and Infectious Diseases Clinical Trials and Mycoses Study Group Collaborators. Ann Intern Med, 1993. 118(8): p. 610–6.PubMedGoogle Scholar
  37. 37.
    Hecht, P.M., et al., Itraconazole maintenance treatment for histoplasmosis in AIDS: a prospective, multicenter trial. J Acquir Immune Defic Syndr Hum Retrovirol, 1997. 16(2): p. 100–7.PubMedGoogle Scholar
  38. 38.
    Goldman, M., et al., Safety of Discontinuation of Maintenance Therapy for Disseminated Histoplasmosis after Immunologic Response to Antiretroviral Therapy: AIDS Clinical Trials Group Study A5038. Clinical Iinfectious Diseases, 2004:38 (15 May). In press.Google Scholar
  39. 39.
    Wheat, J., et al., Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trial Group. Am J Med, 1995. 98(4): p. 336–42.PubMedCrossRefGoogle Scholar
  40. 40.
    Wheat, J., et al., Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Acquired Immunodeficiency Syndrome Clinical Trials Group and Mycoses Study Group. Am J Med, 1997. 103(3): p. 223–32.PubMedGoogle Scholar
  41. 41.
    Johnson, P.C., et al., Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS. Ann Intern Med, 2002. 137(2): p. 105–9.PubMedGoogle Scholar
  42. 42.
    Furcolow, M.L., et al., Prevalence and incidence studies of human and canine blastomycosis. 1. Cases in the United States, 1885–1968. Am Rev Respir Dis, 1970. 102(1): p. 60–7.PubMedGoogle Scholar
  43. 43.
    Kepron, M.W., et al., North American blastomycosis in Central Canada. A review of 36 cases. Can Med Assoc J, 1972. 106(3): p. 243–6.PubMedGoogle Scholar
  44. 44.
    Tosh, F.E., et al., A common source epidemic of North American blastomycosis. Am Rev Respir Dis, 1974. 109(5): p. 525–9.PubMedGoogle Scholar
  45. 45.
    Greenberg, S.B., Serious waterborne and wilderness infections. Crit Care Clin, 1999. 15(2): p. 387–414.PubMedGoogle Scholar
  46. 46.
    Baumgardner, D. J. and K. Brockman, Epidemiology of human blastomycosis in Vilas County, Wisconsin. II: 1991–1996. Wmj, 1998. 97(5): p. 44–7.PubMedGoogle Scholar
  47. 47.
    Sarosi, G. A., et al., Canine blastomycosis as a harbinger of human disease. Ann Intern Med, 1979. 91(5): p. 733–5.PubMedGoogle Scholar
  48. 48.
    Witorsch, P. and J.P. Utz, North American blastomycosis: a study of 40 patients. Medicine (Baltimore), 1968. 47(3): p. 169–200.Google Scholar
  49. 49.
    Klein, B.S., et al., Isolation of Blastomyces dermatitidis in soil associated with a large outbreak of blastomycosis in Wisconsin. N Engl J Med, 1986. 314(9): p. 529–34.PubMedCrossRefGoogle Scholar
  50. 50.
    Klein, B.S., J.M. Vergeront, and J.P. Davis, Epidemiologic aspects of blastomycosis, the enigmatic systemic mycosis. Semin Respir Infect, 1986. 1(1): p. 29–39.PubMedGoogle Scholar
  51. 51.
    Abernathy, R.S., Clinical manifestations of pulmonary blastomycosis. Ann Intern Med, 1959. 51: p. 707–27.PubMedGoogle Scholar
  52. 52.
    Laskey, W. and G.A. Sarosi, The radiological appearance of pulmonary blastomycosis. Radiology, 1978. 126(2): p. 351–7.PubMedGoogle Scholar
  53. 53.
    Davies, S. and G. Sarosi, Clinical manifestations and management of blastomycosis in the compromised patient. In Warnock DW, Richard MD (eds): Fungal Infection in the Compromised Patient. New York: John Wiley & Sons, 1982, 1982: p. 215–229.Google Scholar
  54. 54.
    Pappas, P.G., et al., Blastomycosis in patients with the acquired immunodeficiency syndrome. Ann Intern Med, 1992. 116(10): p. 847–53.PubMedGoogle Scholar
  55. 55.
    Trumbull, M.L. and T.M. Chesney, The cytological diagnosis of pulmonary blastomycosis. Jama, 1981. 245(8): p. 836–8.PubMedCrossRefGoogle Scholar
  56. 56.
    Martynowicz, M.A. and U.B. Prakash, Pulmonary blastomycosis: an appraisal of diagnostic techniques. Chest, 2002. 121(3): p. 768–73.PubMedCrossRefGoogle Scholar
  57. 57.
    Lemos, L.B., M. Guo, and M. Baliga, Blastomycosis: organ involvement and etiologic diagnosis. A review of 123 patients from Mississippi. Ann Diagn Pathol, 2000. 4(6): p. 391–406.PubMedGoogle Scholar
  58. 58.
    Gonyea, E.F., The spectrum of primary blastomycotic meningitis: a review of central nervous system blastomycosis. Ann Neurol, 1978. 3(1): p. 26–39.PubMedCrossRefGoogle Scholar
  59. 59.
    Kravitz, G.R., et al., Chronic blastomycotic meningitis. Am J Med, 1981. 71(3): p. 501–5.PubMedCrossRefGoogle Scholar
  60. 60.
    Flynn, N.M., et al., An unusual outbreak of windborne coccidioidomycosis. N Engl J Med, 1979. 301(7): p. 358–61.PubMedCrossRefGoogle Scholar
  61. 61.
    Werner, S.B., et al., An epidemic of coccidioidomycosis among archeology students in northern California. N Engl J Med, 1972. 286(10): p. 507–12.PubMedCrossRefGoogle Scholar
  62. 62.
    Drutz, D.J. and A. Catanzaro, Coccidioidomycosis. Part II. Am Rev Respir Dis, 1978. 117(4): p. 727–71.PubMedGoogle Scholar
  63. 63.
    Bouza, E., et al., Coccidioidal meningitis. An analysis of thirty-one cases and review of the literature. Medicine (Baltimore), 1981. 60(3): p. 139–72.Google Scholar
  64. 64.
    Bayer, A.S., et al., Unusual syndromes of coccidioidomycosis: diagnostic and therapeutic considerations; a report of 10 cases and review of the English literature. Medicine (Baltimore), 1976. 55(2): p. 131–52.Google Scholar
  65. 65.
    Bayer, A.S., Fungal pneumonias; pulmonary coccidioidal syndromes (Part I). Primary and progressive primary coccidioidal pneumonias — diagnostic, therapeutic, and prognostic considerations. Chest, 1981. 79(5): p. 575–83.PubMedGoogle Scholar
  66. 66.
    Winn, W.A., A long term study of 300 patients with cavitary-abscess lesions of the lung of coccidioidal origin. An analytical study with special reference to treatment. Dis Chest, 1968. 54: p. Suppl 1:268+.PubMedGoogle Scholar
  67. 67.
    Rutala, P.J. and J.W. Smith, Coccidioidomycosis in potentially compromised hosts: the effect of immunosuppressive therapy in dissemination. Am J Med Sci, 1978. 275(3): p. 283–95.PubMedCrossRefGoogle Scholar
  68. 68.
    Cohen, I.M., et al., Coccidioidomycosis in renal replacement therapy. Arch Intern Med, 1982. 142(3): p. 489–94.PubMedCrossRefGoogle Scholar
  69. 69.
    Blair, J.E., D.D. Douglas, and D.C. Mulligan, Early results of targeted prophylaxis for coccidioidomycosis in patients undergoing orthotopic liver transplantation within an endemic area. Transpl Infect Dis, 2003. 5(1): p. 3–8.PubMedGoogle Scholar
  70. 70.
    Bronnimann, D.A., et al., Coccidioidomycosis in the acquired immunodeficiency syndrome. Ann Intern Med, 1987. 106(3): p. 372–9.PubMedGoogle Scholar
  71. 71.
    Fish, D.G., et al., Coccidioidomycosis during human immunodeficiency virus infection. A review of 77 patients. Medicine (Baltimore), 1990. 69(6): p. 384–91.Google Scholar
  72. 72.
    Warlick, M.A., S.F. Quan, and R.E. Sobonya, Rapid diagnosis of pulmonary coccidioidomycosis. Cytologic v potassium hydroxide preparations. Arch Intern Med, 1983. 143(4): p. 723–5.PubMedCrossRefGoogle Scholar
  73. 73.
    Wallace, J.M., et al., Flexible fiberoptic bronchoscopy for diagnosing pulmonary coccidioidomycosis. Am Rev Respir Dis, 1981. 123(3): p. 286–90.PubMedGoogle Scholar
  74. 74.
    Polesky, A., et al., Airway coccidioidomycosis—report of cases and review. Clin Infect Dis, 1999. 28(6): p. 1273–80.PubMedGoogle Scholar
  75. 75.
    Mahaffey, K.W., et al., Unrecognized coccidioidomycosis complicating Pneumocystis carinii pneumonia in patients infected with the human immunodeficiency virus and treated with corticosteroids. A report of two cases. Arch Intern Med, 1993. 153(12): p. 1496–8.PubMedCrossRefGoogle Scholar
  76. 76.
    Sobonya, R.E., et al., Detection of fungi and other pathogens in immunocompromised patients by bronchoalveolar lavage in an area endemic for coccidioidomycosis. Chest, 1990. 97(6): p. 1349–55.PubMedGoogle Scholar
  77. 77.
    Sarosi, G.A., et al., Rapid diagnostic evaluation of bronchial washings in patients with suspected coccidioidomycosis. Semin Respir Infect, 2001. 16(4): p. 238–41.PubMedGoogle Scholar
  78. 78.
    Standard, P.G. and L. Kaufman, Immunological procedure for the rapid and specific identification of Coccidioides immitis cultures. J Clin Microbiol, 1977. 5(2): p. 149–53.PubMedGoogle Scholar
  79. 79.
    Smith, C.E., M.T. Saito, and S. A. Simons, Pattern of 39,500 serologic tests in coccidioidomycosis. J Am Med Assoc, 1956. 160(7): p. 546–52.PubMedGoogle Scholar
  80. 80.
    Galgiani, J.N., et al., Practice guideline for the treatment of coccidioidomycosis. Infectious Diseases Society of America. Clin Infect Dis, 2000. 30(4): p. 658–61.PubMedCrossRefGoogle Scholar
  81. 81.
    Bennett, J.E., Chemotherapy of systemic mycoses (first of two parts). N Engl J Med, 1974. 290(1): p. 30–2.PubMedCrossRefGoogle Scholar
  82. 82.
    Galgiani, J.N., et al., Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis. A randomized, double-blind trial. Mycoses Study Group. Ann Intern Med, 2000. 133(9): p. 676–86.PubMedGoogle Scholar
  83. 83.
    Diamond, R.D. and J.E. Bennett, A subcutaneous reservoir for intrathecal therapy of fungal meningitis. N Engl J Med, 1973. 288(4): p. 186–8.PubMedCrossRefGoogle Scholar
  84. 84.
    Dewsnup, D.H., et al., Is it ever safe to stop azole therapy for Coccidioides immitis meningitis? Ann Intern Med, 1996. 124(3): p. 305–10.PubMedGoogle Scholar

Copyright information

© Springer Science + Business Media, Inc. 2005

Authors and Affiliations

  • Chadi A. Hage
    • 1
  • Kenneth S. Knox
    • 1
  • George A. Sarosi
    • 1
  1. 1.Indiana University- School of Medicine, and Roudebush VA Medical CenterIndianapolisUSA

Personalised recommendations